OTCMKTS:BETRF

BetterLife Pharma News Headlines

$0.66
-0.01 (-1.49 %)
(As of 04/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.66
Now: $0.66
$0.72
50-Day Range
$0.67
MA: $1.03
$1.20
52-Week Range
$0.25
Now: $0.66
$2.59
Volume24,489 shs
Average Volume85,848 shs
Market Capitalization$11.37 million
P/E RatioN/A
Dividend YieldN/A
Beta3.8

Headlines

BetterLife Pharma (OTCMKTS BETRF) News Headlines Today

SourceHeadline
BetterLife Pharma Inc. (OTCMKTS:BETRF) Short Interest Up 3,000.0% in MarchBetterLife Pharma Inc. (OTCMKTS:BETRF) Short Interest Up 3,000.0% in March
americanbankingnews.com - April 13 at 5:14 AM
Former FDA Psychiatry Division Director Dr. Thomas Laughren Joins BetterLife as Regulatory AdvisorFormer FDA Psychiatry Division Director Dr. Thomas Laughren Joins BetterLife as Regulatory Advisor
finance.yahoo.com - April 8 at 12:27 PM
BetterLife Added to Horizons Psychedelic Stock Index ETFBetterLife Added to Horizons Psychedelic Stock Index ETF
finance.yahoo.com - March 29 at 9:31 AM
Short Interest in BetterLife Pharma Inc. (OTCMKTS:BETRF) Declines By 61.5%Short Interest in BetterLife Pharma Inc. (OTCMKTS:BETRF) Declines By 61.5%
americanbankingnews.com - March 28 at 8:06 AM
BetterLife Pharma says subsidiary Altum Pharmaceuticals to conduct coronavirus trial in Chile using its AP-003BetterLife Pharma says subsidiary Altum Pharmaceuticals to conduct coronavirus trial in Chile using its AP-003
proactiveinvestors.com - March 26 at 8:56 PM
BetterLife Pharma inks research agreement with the University of California San DiegoBetterLife Pharma inks research agreement with the University of California San Diego
proactiveinvestors.com - March 26 at 8:56 PM
BetterLife Pharma: BetterLife Enters Into Research Agreement with UCSD for TD-0148A Behavioural Pharmacology StudiesBetterLife Pharma: BetterLife Enters Into Research Agreement with UCSD for TD-0148A Behavioural Pharmacology Studies
finanznachrichten.de - March 24 at 12:53 PM
BetterLife Enters Into Research Agreement with UCSD for TD-0148A Behavioural Pharmacology StudiesBetterLife Enters Into Research Agreement with UCSD for TD-0148A Behavioural Pharmacology Studies
finance.yahoo.com - March 24 at 12:53 PM
BetterLife Subsidiary, Altum Pharmaceuticals, to Conduct Randomized Placebo-controlled COVID-19 Trial Using AP-003BetterLife Subsidiary, Altum Pharmaceuticals, to Conduct Randomized Placebo-controlled COVID-19 Trial Using AP-003
finance.yahoo.com - March 11 at 12:21 PM
BetterLife Pharma announces tie-up with Carleton University to study TD-0148A as treatment for depressionBetterLife Pharma announces tie-up with Carleton University to study TD-0148A as treatment for depression
proactiveinvestors.com - March 10 at 8:32 AM
BetterLife Enters Research Agreement with Carleton University for TD-0148A Depression StudiesBetterLife Enters Research Agreement with Carleton University for TD-0148A Depression Studies
finance.yahoo.com - March 8 at 8:09 AM
BetterLife Pharma hires Eurofins CDMO to manufacture LSD derivative TD-0148ABetterLife Pharma hires Eurofins CDMO to manufacture LSD derivative TD-0148A
proactiveinvestors.com - March 3 at 2:50 PM
BetterLife Engages Eurofins CDMO for Next Generation Psychedelic TD-0148A ManufacturingBetterLife Engages Eurofins CDMO for Next Generation Psychedelic TD-0148A Manufacturing
finance.yahoo.com - March 3 at 9:50 AM
BetterLife Pharma files patent protection for its newest compound TD-010 to treat anxiolytic-use disorderBetterLife Pharma files patent protection for its newest compound TD-010 to treat anxiolytic-use disorder
proactiveinvestors.com - February 2 at 12:29 PM
BetterLife Files Patent Protection on Dihydrohonokiol-B for Treatment of Anxiolytic Use DisorderBetterLife Files Patent Protection on Dihydrohonokiol-B for Treatment of Anxiolytic Use Disorder
finance.yahoo.com - February 2 at 12:29 PM
BetterLife Pharma inhaled coronavirus treatment passes six months of cold temperature testsBetterLife Pharma inhaled coronavirus treatment passes six months of cold temperature tests
proactiveinvestors.com - January 28 at 8:16 PM
BetterLife Pharma partners with Eurofins Discovery for pharmacology studies of Eurofins LSD-derived molecule TD-0148ABetterLife Pharma partners with Eurofins Discovery for pharmacology studies of Eurofins' LSD-derived molecule TD-0148A
proactiveinvestors.com - January 28 at 10:15 AM
BetterLife Demonstrates 6 months Refrigerated Stability of its Proprietary Interferon Formulation to be Developed to Treat Early Stage Covid-19 CasesBetterLife Demonstrates 6 months Refrigerated Stability of its Proprietary Interferon Formulation to be Developed to Treat Early Stage Covid-19 Cases
benzinga.com - January 26 at 11:23 AM
BetterLife Pharma inhaled coronavirus treatment passes six months of cold temperture testsBetterLife Pharma inhaled coronavirus treatment passes six months of cold temperture tests
proactiveinvestors.com - January 26 at 11:23 AM
BetterLife Selects CRO to Conduct Clinical Trials for AP-003 in COVID-19 Cases in IndonesiaBetterLife Selects CRO to Conduct Clinical Trials for AP-003 in COVID-19 Cases in Indonesia
benzinga.com - January 21 at 9:33 AM
BetterLife Selects CRO to Conduct Clinical Trials for AP-003 in COVID-19 Cases in IndonesiaBetterLife Selects CRO to Conduct Clinical Trials for AP-003 in COVID-19 Cases in Indonesia
finance.yahoo.com - January 21 at 9:33 AM
BetterLife Confirms Non-controlled Status of 2-bromo-LSD with Health CanadaBetterLife Confirms Non-controlled Status of 2-bromo-LSD with Health Canada
finance.yahoo.com - January 19 at 6:48 PM
BetterLife Provides Shareholder Update and 2021 Product Development RoadmapBetterLife Provides Shareholder Update and 2021 Product Development Roadmap
markets.businessinsider.com - January 12 at 2:22 AM
BetterLife Announces Formation of Next Generation Psychedelic Research Advisory BoardBetterLife Announces Formation of Next Generation Psychedelic Research Advisory Board
finance.yahoo.com - January 7 at 11:41 AM
BetterLife Closes Acquisition of Second Generation Psychedelic Assets of Transcend Biodynamics LLCBetterLife Closes Acquisition of Second Generation Psychedelic Assets of Transcend Biodynamics LLC
feeds.benzinga.com - December 21 at 3:07 AM
BetterLife Pharmas new acquisition takes LSD from being experimental to a major therapeutic applicationBetterLife Pharma's new acquisition takes LSD from being experimental to a major therapeutic application
proactiveinvestors.com - December 17 at 12:16 AM
BetterLife PharmaBetterLife Pharma
benzinga.com - December 16 at 7:14 PM
BetterLife’s Recent Acquisition: Taking LSD from Experimental to a Major Therapeutic ApplicationBetterLife’s Recent Acquisition: Taking LSD from Experimental to a Major Therapeutic Application
finance.yahoo.com - December 15 at 4:03 AM
BetterLifes Recent Acquisition: Taking LSD from Experimental to a Major Therapeutic ApplicationBetterLife's Recent Acquisition: Taking LSD from Experimental to a Major Therapeutic Application
benzinga.com - December 15 at 2:19 AM
NA Proactive news snapshot: RedHill Biopharma, PyroGenesis, American Manganese, BetterLife Pharma UPDATENA Proactive news snapshot: RedHill Biopharma, PyroGenesis, American Manganese, BetterLife Pharma UPDATE
proactiveinvestors.com - December 8 at 3:29 PM
BetterLife Provides Important Update on its Australian Clinical Study DesignBetterLife Provides Important Update on its Australian Clinical Study Design
finance.yahoo.com - December 4 at 11:53 AM
BetterLife Pharma Signs eTMF Partner to Help Accelerate AP-003 Clinical Trial OperationsBetterLife Pharma Signs eTMF Partner to Help Accelerate AP-003 Clinical Trial Operations
finance.yahoo.com - December 4 at 11:53 AM
Pre-IND Discussion with U.S. FDA Helps BetterLife Set Up AP-003 Clinical Trials in AustraliaPre-IND Discussion with U.S. FDA Helps BetterLife Set Up AP-003 Clinical Trials in Australia
finance.yahoo.com - December 4 at 11:53 AM
What do the Pfizer Vaccine and BetterLife Pharma have in common?What do the Pfizer Vaccine and BetterLife Pharma have in common?
finance.yahoo.com - December 4 at 11:53 AM
BETTERLIFE PHARMA ANNOUNCES CLOSING OF $2.9 MILLION PRIVATE PLACEMENT OFFERINGBETTERLIFE PHARMA ANNOUNCES CLOSING OF $2.9 MILLION PRIVATE PLACEMENT OFFERING
finance.yahoo.com - December 4 at 11:53 AM
This page was last updated on 4/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.